ES2383990T3 - Endonucleasas FEN - Google Patents

Info

Publication number

ES2383990T3

ES2383990T3 ES04019258T ES04019258T ES2383990T3 ES 2383990 T3 ES2383990 T3 ES 2383990T3 ES 04019258 T ES04019258 T ES 04019258T ES 04019258 T ES04019258 T ES 04019258T ES 2383990 T3 ES2383990 T3 ES 2383990T3

Authority

ES

Spain

Prior art keywords

oligonucleotide

nucleic acid

cleavage

target

probe

Prior art date

2000-11-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Lifetime

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000652 Flap endonucleases Proteins 0.000 claims abstract description 138
• 102000004150 Flap endonucleases Human genes 0.000 claims abstract description 86
• 239000000203 mixture Substances 0.000 claims abstract description 65
• 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 38
• 108091034117 Oligonucleotide Proteins 0.000 claims description 733
• 238000003776 cleavage reaction Methods 0.000 claims description 539
• 230000007017 scission Effects 0.000 claims description 490
• 150000007523 nucleic acids Chemical class 0.000 claims description 440
• 102000039446 nucleic acids Human genes 0.000 claims description 384
• 108020004707 nucleic acids Proteins 0.000 claims description 384
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 205
• 238000000034 method Methods 0.000 claims description 146
• 101710163270 Nuclease Proteins 0.000 claims description 134
• 125000003729 nucleotide group Chemical group 0.000 claims description 120
• 239000002773 nucleotide Substances 0.000 claims description 117
• 230000000694 effects Effects 0.000 claims description 103
• 230000000295 complement effect Effects 0.000 claims description 100
• 102000004190 Enzymes Human genes 0.000 claims description 96
• 108090000790 Enzymes Proteins 0.000 claims description 96
• 229940088598 enzyme Drugs 0.000 claims description 96
• 238000011144 upstream manufacturing Methods 0.000 claims description 65
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 57
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 56
• 108010042407 Endonucleases Proteins 0.000 claims description 35
• 102000004533 Endonucleases Human genes 0.000 claims description 24
• 108010041758 cleavase Proteins 0.000 claims description 24
• 239000013598 vector Substances 0.000 claims description 13
• 241000589500 Thermus aquaticus Species 0.000 claims description 12
• 150000001768 cations Chemical class 0.000 claims description 12
• 241000588724 Escherichia coli Species 0.000 claims description 11
• 239000007787 solid Substances 0.000 claims description 11
• 241000726121 Acidianus Species 0.000 claims description 10
• 241000204641 Methanopyrus kandleri Species 0.000 claims description 10
• 241001494984 Pyrodictium brockii Species 0.000 claims description 10
• 241001237851 Thermococcus gorgonarius Species 0.000 claims description 10
• 241000529868 Thermococcus zilligii Species 0.000 claims description 10
• 108090000190 Thrombin Proteins 0.000 claims description 10
• 230000002829 reductive effect Effects 0.000 claims description 10
• 241000567139 Aeropyrum pernix Species 0.000 claims description 9
• 241000203373 Methanotorris igneus Species 0.000 claims description 9
• 241000736843 Pyrobaculum aerophilum Species 0.000 claims description 9
• 241000522615 Pyrococcus horikoshii Species 0.000 claims description 9
• 241000205091 Sulfolobus solfataricus Species 0.000 claims description 9
• 241000205180 Thermococcus litoralis Species 0.000 claims description 9
• 241000205069 Acidianus ambivalens Species 0.000 claims description 7
• 241000359383 Desulfurococcus amylolyticus Species 0.000 claims description 7
• 241000205229 Desulfurococcus mucosus Species 0.000 claims description 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 6
• 239000007853 buffer solution Substances 0.000 claims description 5
• 101100491149 Caenorhabditis elegans lem-3 gene Proteins 0.000 claims description 4
• 108010085671 Thermus thermophilus DNA polymerase Proteins 0.000 claims description 4
• 238000010306 acid treatment Methods 0.000 claims description 4
• 239000000523 sample Substances 0.000 description 457
• 238000006243 chemical reaction Methods 0.000 description 299
• 239000000047 product Substances 0.000 description 210
• 238000001514 detection method Methods 0.000 description 134
• 108090000623 proteins and genes Proteins 0.000 description 112
• 102000053602 DNA Human genes 0.000 description 93
• 238000003556 assay Methods 0.000 description 93
• 108020004414 DNA Proteins 0.000 description 91
• 230000027455 binding Effects 0.000 description 64
• 239000003795 chemical substances by application Substances 0.000 description 59
• 238000009396 hybridization Methods 0.000 description 58
• 239000000758 substrate Substances 0.000 description 55
• 238000012632 fluorescent imaging Methods 0.000 description 51
• 239000013615 primer Substances 0.000 description 51
• 235000018102 proteins Nutrition 0.000 description 51
• 102000004169 proteins and genes Human genes 0.000 description 51
• 238000012360 testing method Methods 0.000 description 48
• 150000001413 amino acids Chemical class 0.000 description 47
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 44
• 238000003752 polymerase chain reaction Methods 0.000 description 44
• 238000010586 diagram Methods 0.000 description 40
• 108700028369 Alleles Proteins 0.000 description 38
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 38
• 239000012634 fragment Substances 0.000 description 35
• 238000013461 design Methods 0.000 description 32
• 229940024606 amino acid Drugs 0.000 description 31
• 235000001014 amino acid Nutrition 0.000 description 31
• 230000003321 amplification Effects 0.000 description 31
• 238000003199 nucleic acid amplification method Methods 0.000 description 31
• 238000004458 analytical method Methods 0.000 description 30
• 239000000499 gel Substances 0.000 description 30
• 230000015572 biosynthetic process Effects 0.000 description 28
• 230000001419 dependent effect Effects 0.000 description 26
• 239000003550 marker Substances 0.000 description 24
• 108091028043 Nucleic acid sequence Proteins 0.000 description 23
• 241000282414 Homo sapiens Species 0.000 description 22
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 21
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 20
• 239000002751 oligonucleotide probe Substances 0.000 description 20
• 230000036961 partial effect Effects 0.000 description 19
• 239000002609 medium Substances 0.000 description 18
• 241000589499 Thermus thermophilus Species 0.000 description 17
• 230000035772 mutation Effects 0.000 description 17
• 230000008569 process Effects 0.000 description 17
• 238000000926 separation method Methods 0.000 description 17
• 239000000243 solution Substances 0.000 description 17
• 238000003786 synthesis reaction Methods 0.000 description 17
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
• 210000004027 cell Anatomy 0.000 description 16
• 230000006870 function Effects 0.000 description 16
• 230000001965 increasing effect Effects 0.000 description 16
• 150000003839 salts Chemical class 0.000 description 16
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 15
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 15
• 230000004048 modification Effects 0.000 description 15
• 238000012986 modification Methods 0.000 description 15
• 108090000765 processed proteins & peptides Proteins 0.000 description 15
• 238000010517 secondary reaction Methods 0.000 description 15
• 239000007795 chemical reaction product Substances 0.000 description 14
• 230000008901 benefit Effects 0.000 description 13
• 150000001875 compounds Chemical class 0.000 description 13
• 239000000463 material Substances 0.000 description 13
• UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 13
• 238000013518 transcription Methods 0.000 description 13
• 230000035897 transcription Effects 0.000 description 13
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
• 238000005516 engineering process Methods 0.000 description 12
• 230000007935 neutral effect Effects 0.000 description 12
• 229920001184 polypeptide Polymers 0.000 description 12
• 102000004196 processed proteins & peptides Human genes 0.000 description 12
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 11
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 11
• 102100031780 Endonuclease Human genes 0.000 description 11
• 108010010677 Phosphodiesterase I Proteins 0.000 description 11
• 239000002253 acid Substances 0.000 description 11
• 238000000211 autoradiogram Methods 0.000 description 11
• 238000001962 electrophoresis Methods 0.000 description 11
• 230000006872 improvement Effects 0.000 description 11
• -1 nucleoside triphosphate Chemical class 0.000 description 11
• 241000205156 Pyrococcus furiosus Species 0.000 description 10
• 239000000872 buffer Substances 0.000 description 10
• 239000000975 dye Substances 0.000 description 10
• 230000003993 interaction Effects 0.000 description 10
• 239000000543 intermediate Substances 0.000 description 10
• 230000007246 mechanism Effects 0.000 description 10
• 210000004940 nucleus Anatomy 0.000 description 10
• 102000040430 polynucleotide Human genes 0.000 description 10
• 108091033319 polynucleotide Proteins 0.000 description 10
• 239000002157 polynucleotide Substances 0.000 description 10
• 241000894006 Bacteria Species 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 239000012491 analyte Substances 0.000 description 9
• 210000004899 c-terminal region Anatomy 0.000 description 9
• 230000015556 catabolic process Effects 0.000 description 9
• 239000003153 chemical reaction reagent Substances 0.000 description 9
• 238000006731 degradation reaction Methods 0.000 description 9
• 239000001226 triphosphate Substances 0.000 description 9
• 235000011178 triphosphate Nutrition 0.000 description 9
• 241000205042 Archaeoglobus fulgidus Species 0.000 description 8
• 229910019142 PO4 Inorganic materials 0.000 description 8
• 102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 8
• 108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 8
• 241000205192 Pyrococcus woesei Species 0.000 description 8
• 108020004511 Recombinant DNA Proteins 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 230000009471 action Effects 0.000 description 8
• 229960002685 biotin Drugs 0.000 description 8
• 235000020958 biotin Nutrition 0.000 description 8
• 239000011616 biotin Substances 0.000 description 8
• 210000004369 blood Anatomy 0.000 description 8
• 239000008280 blood Substances 0.000 description 8
• 238000004364 calculation method Methods 0.000 description 8
• 230000014509 gene expression Effects 0.000 description 8
• 239000002777 nucleoside Substances 0.000 description 8
• 239000010452 phosphate Substances 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 229960004072 thrombin Drugs 0.000 description 8
• 108060002716 Exonuclease Proteins 0.000 description 7
• 241000203407 Methanocaldococcus jannaschii Species 0.000 description 7
• 206010028980 Neoplasm Diseases 0.000 description 7
• 238000011109 contamination Methods 0.000 description 7
• 230000001351 cycling effect Effects 0.000 description 7
• 230000002255 enzymatic effect Effects 0.000 description 7
• 102000013165 exonuclease Human genes 0.000 description 7
• 230000001976 improved effect Effects 0.000 description 7
• 238000002844 melting Methods 0.000 description 7
• 230000008018 melting Effects 0.000 description 7
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 7
• 239000000376 reactant Substances 0.000 description 7
• 239000011541 reaction mixture Substances 0.000 description 7
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 6
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 6
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 6
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
• 230000003247 decreasing effect Effects 0.000 description 6
• 239000005546 dideoxynucleotide Substances 0.000 description 6
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 6
• 108020001507 fusion proteins Proteins 0.000 description 6
• 102000037865 fusion proteins Human genes 0.000 description 6
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
• 244000005700 microbiome Species 0.000 description 6
• 230000005012 migration Effects 0.000 description 6
• 238000013508 migration Methods 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
• 235000021317 phosphate Nutrition 0.000 description 6
• 238000006116 polymerization reaction Methods 0.000 description 6
• 230000010076 replication Effects 0.000 description 6
• 230000035945 sensitivity Effects 0.000 description 6
• 238000004904 shortening Methods 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 241000894007 species Species 0.000 description 6
• 241001112695 Clostridiales Species 0.000 description 5
• 108091026890 Coding region Proteins 0.000 description 5
• 108010014172 Factor V Proteins 0.000 description 5
• 101100394766 Homo sapiens HFE gene Proteins 0.000 description 5
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 5
• 241000589596 Thermus Species 0.000 description 5
• 238000009825 accumulation Methods 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 238000012512 characterization method Methods 0.000 description 5
• 238000005520 cutting process Methods 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 230000029087 digestion Effects 0.000 description 5
• 238000010494 dissociation reaction Methods 0.000 description 5
• 230000005593 dissociations Effects 0.000 description 5
• 230000010534 mechanism of action Effects 0.000 description 5
• 238000007899 nucleic acid hybridization Methods 0.000 description 5
• HMFHBZSHGGEWLO-UHFFFAOYSA-N pentofuranose Chemical group OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 5
• 235000000346 sugar Nutrition 0.000 description 5
• QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 4
• 102000012410 DNA Ligases Human genes 0.000 description 4
• 108010061982 DNA Ligases Proteins 0.000 description 4
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 4
• 241000233866 Fungi Species 0.000 description 4
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
• 241000711549 Hepacivirus C Species 0.000 description 4
• 102000003960 Ligases Human genes 0.000 description 4
• 108090000364 Ligases Proteins 0.000 description 4
• 108020004682 Single-Stranded DNA Proteins 0.000 description 4
• 108010090804 Streptavidin Proteins 0.000 description 4
• 108010006785 Taq Polymerase Proteins 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000006399 behavior Effects 0.000 description 4
• 238000012937 correction Methods 0.000 description 4
• 230000002950 deficient Effects 0.000 description 4
• 238000004925 denaturation Methods 0.000 description 4
• 230000036425 denaturation Effects 0.000 description 4
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 4
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 4
• 238000006073 displacement reaction Methods 0.000 description 4
• 239000012467 final product Substances 0.000 description 4
• 229910052731 fluorine Inorganic materials 0.000 description 4
• 239000000833 heterodimer Substances 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 238000005457 optimization Methods 0.000 description 4
• 239000000049 pigment Substances 0.000 description 4
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 238000011282 treatment Methods 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 241000203069 Archaea Species 0.000 description 3
• 241000972773 Aulopiformes Species 0.000 description 3
• 101100008044 Caenorhabditis elegans cut-1 gene Proteins 0.000 description 3
• 241000223782 Ciliophora Species 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• 108010017826 DNA Polymerase I Proteins 0.000 description 3
• 102000004594 DNA Polymerase I Human genes 0.000 description 3
• 102100031866 DNA excision repair protein ERCC-5 Human genes 0.000 description 3
• 239000003298 DNA probe Substances 0.000 description 3
• 230000004543 DNA replication Effects 0.000 description 3
• 102100026121 Flap endonuclease 1 Human genes 0.000 description 3
• 101000913035 Homo sapiens Flap endonuclease 1 Proteins 0.000 description 3
• 101000651439 Homo sapiens Prothrombin Proteins 0.000 description 3
• 241000203353 Methanococcus Species 0.000 description 3
• RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 3
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
• 239000012472 biological sample Substances 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 239000006227 byproduct Substances 0.000 description 3
• 239000002131 composite material Substances 0.000 description 3
• 229940104302 cytosine Drugs 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 230000005684 electric field Effects 0.000 description 3
• 230000007613 environmental effect Effects 0.000 description 3
• 230000001036 exonucleolytic effect Effects 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 238000002875 fluorescence polarization Methods 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 238000010353 genetic engineering Methods 0.000 description 3
• 239000003292 glue Substances 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 150000002500 ions Chemical class 0.000 description 3
• 238000007834 ligase chain reaction Methods 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 230000013011 mating Effects 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 229960003085 meticillin Drugs 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 210000004897 n-terminal region Anatomy 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 230000009871 nonspecific binding Effects 0.000 description 3
• 102000044158 nucleic acid binding protein Human genes 0.000 description 3
• 108700020942 nucleic acid binding protein Proteins 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 230000008488 polyadenylation Effects 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 230000003252 repetitive effect Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 210000003296 saliva Anatomy 0.000 description 3
• 235000019515 salmon Nutrition 0.000 description 3
• 238000012163 sequencing technique Methods 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 108010068698 spleen exonuclease Proteins 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 3
• 230000007306 turnover Effects 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
• LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 2
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 2
• HECJQIPEEHNWCS-UHFFFAOYSA-N 4-propyl-2h-triazole Chemical compound CCCC1=CNN=N1 HECJQIPEEHNWCS-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• OHOQEZWSNFNUSY-UHFFFAOYSA-N Cy3-bifunctional dye zwitterion Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCN1C2=CC=C(S(O)(=O)=O)C=C2C(C)(C)C1=CC=CC(C(C1=CC(=CC=C11)S([O-])(=O)=O)(C)C)=[N+]1CCCCCC(=O)ON1C(=O)CCC1=O OHOQEZWSNFNUSY-UHFFFAOYSA-N 0.000 description 2
• 108020003215 DNA Probes Proteins 0.000 description 2
• 108010035476 DNA excision repair protein ERCC-5 Proteins 0.000 description 2
• 230000006820 DNA synthesis Effects 0.000 description 2
• 230000004568 DNA-binding Effects 0.000 description 2
• 241000205236 Desulfurococcus Species 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 102100033962 GTP-binding protein RAD Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101100514680 Homo sapiens MTHFR gene Proteins 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
• 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
• GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 206010036790 Productive cough Diseases 0.000 description 2
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
• 241000191984 Staphylococcus haemolyticus Species 0.000 description 2
• 101710137500 T7 RNA polymerase Proteins 0.000 description 2
• 108020004566 Transfer RNA Proteins 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 238000006555 catalytic reaction Methods 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 230000000875 corresponding effect Effects 0.000 description 2
• 238000012864 cross contamination Methods 0.000 description 2
• 235000013365 dairy product Nutrition 0.000 description 2
• 239000005547 deoxyribonucleotide Substances 0.000 description 2
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
• 229960005542 ethidium bromide Drugs 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 229940039715 human prothrombin Drugs 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 239000012678 infectious agent Substances 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 210000002751 lymph Anatomy 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 229910052748 manganese Inorganic materials 0.000 description 2
• 239000011572 manganese Substances 0.000 description 2
• 239000011565 manganese chloride Substances 0.000 description 2
• 235000002867 manganese chloride Nutrition 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 235000013372 meat Nutrition 0.000 description 2
• 101150008979 mecA gene Proteins 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 238000001823 molecular biology technique Methods 0.000 description 2
• 101150100619 nuc gene Proteins 0.000 description 2
• 150000003833 nucleoside derivatives Chemical class 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• 210000004910 pleural fluid Anatomy 0.000 description 2
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
• 235000004252 protein component Nutrition 0.000 description 2
• 230000006337 proteolytic cleavage Effects 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 150000003212 purines Chemical class 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 102200071191 rs1799945 Human genes 0.000 description 2
• 210000000582 semen Anatomy 0.000 description 2
• 238000011895 specific detection Methods 0.000 description 2
• 210000003802 sputum Anatomy 0.000 description 2
• 208000024794 sputum Diseases 0.000 description 2
• 230000000087 stabilizing effect Effects 0.000 description 2
• 150000003852 triazoles Chemical class 0.000 description 2
• XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• STGXGJRRAJKJRG-JDJSBBGDSA-N (3r,4r,5r)-5-(hydroxymethyl)-3-methoxyoxolane-2,4-diol Chemical compound CO[C@H]1C(O)O[C@H](CO)[C@H]1O STGXGJRRAJKJRG-JDJSBBGDSA-N 0.000 description 1
• LFRDGHVRPSURMV-YFKPBYRVSA-N (4s)-4,5-dihydroxypentanal Chemical compound OC[C@@H](O)CCC=O LFRDGHVRPSURMV-YFKPBYRVSA-N 0.000 description 1
• OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
• LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
• 208000035657 Abasia Diseases 0.000 description 1
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 108091023037 Aptamer Proteins 0.000 description 1
• 241000593342 Archaeoglobus veneficus Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 101800001288 Atrial natriuretic factor Proteins 0.000 description 1
• 101800001890 Atrial natriuretic peptide Proteins 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 230000008836 DNA modification Effects 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241001524679 Escherichia virus M13 Species 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 102100037091 Exonuclease V Human genes 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• 108050008282 Flap endonuclease Xni Proteins 0.000 description 1
• 206010071602 Genetic polymorphism Diseases 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 241000711557 Hepacivirus Species 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 102100039869 Histone H2B type F-S Human genes 0.000 description 1
• 101000881977 Homo sapiens Exonuclease V Proteins 0.000 description 1
• 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
• 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 1
• 101100099880 Homo sapiens TNF gene Proteins 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 241000283953 Lagomorpha Species 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 239000007993 MOPS buffer Substances 0.000 description 1
• 241000202974 Methanobacterium Species 0.000 description 1
• 108700005443 Microbial Genes Proteins 0.000 description 1
• 108010059724 Micrococcal Nuclease Proteins 0.000 description 1
• 206010048723 Multiple-drug resistance Diseases 0.000 description 1
• 101100390562 Mus musculus Fen1 gene Proteins 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 101150040459 RAS gene Proteins 0.000 description 1
• 101710086015 RNA ligase Proteins 0.000 description 1
• 239000013616 RNA primer Substances 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101100334593 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RAD27 gene Proteins 0.000 description 1
• 101100411616 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rad13 gene Proteins 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000205101 Sulfolobus Species 0.000 description 1
• 241001522143 Thermus scotoductus Species 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 241000282458 Ursus sp. Species 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 238000002441 X-ray diffraction Methods 0.000 description 1
• 101100333723 Xenopus laevis ercc5 gene Proteins 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 230000009102 absorption Effects 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 229940041181 antineoplastic drug Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 230000000712 assembly Effects 0.000 description 1
• 238000000429 assembly Methods 0.000 description 1
• 238000007068 beta-elimination reaction Methods 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 150000001793 charged compounds Chemical class 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 238000004737 colorimetric analysis Methods 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000002153 concerted effect Effects 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 230000001687 destabilization Effects 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 229940079919 digestives enzyme preparation Drugs 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 238000000295 emission spectrum Methods 0.000 description 1
• 239000005447 environmental material Substances 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 238000001952 enzyme assay Methods 0.000 description 1
• GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 101150097017 fen gene Proteins 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 235000012041 food component Nutrition 0.000 description 1
• 238000004374 forensic analysis Methods 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 238000000892 gravimetry Methods 0.000 description 1
• 239000000710 homodimer Substances 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 201000006747 infectious mononucleosis Diseases 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 244000000056 intracellular parasite Species 0.000 description 1
• 238000001155 isoelectric focusing Methods 0.000 description 1
• 230000000155 isotopic effect Effects 0.000 description 1
• 238000005304 joining Methods 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 235000021056 liquid food Nutrition 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 230000005389 magnetism Effects 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 238000009629 microbiological culture Methods 0.000 description 1
• 238000006011 modification reaction Methods 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 230000001293 nucleolytic effect Effects 0.000 description 1
• 230000001151 other effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 229920000768 polyamine Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 230000037048 polymerization activity Effects 0.000 description 1
• 239000012985 polymerization agent Substances 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000000135 prohibitive effect Effects 0.000 description 1
• 230000009465 prokaryotic expression Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 108700042226 ras Genes Proteins 0.000 description 1
• 239000011535 reaction buffer Substances 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 238000011897 real-time detection Methods 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000002787 reinforcement Effects 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• 150000003290 ribose derivatives Chemical class 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 238000011896 sensitive detection Methods 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 238000012772 sequence design Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 238000007086 side reaction Methods 0.000 description 1
• 230000002226 simultaneous effect Effects 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 235000021055 solid food Nutrition 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 239000013077 target material Substances 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 229920001187 thermosetting polymer Polymers 0.000 description 1
• ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical group [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 210000003813 thumb Anatomy 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1